Watch the Webinar Now!
OB/GYN specialist John Allbert, MD, MFM provides the answers needed to help understand the risks, diagnosis and potential treatment of PROM.
This webinar will cover:
Keys to identifying patients with premature rupture of membranes, as well as risk reduction strategies.
Steps to take in patients for whom the diagnosis of premature rupture of membranes is unclear after traditional testing, as well as the potential consequences of false positive and negative diagnoses.
×
Please enter your information to listen to PROM podcast PEARL #2 & #3.
Management of premature rupture of membranes, especially in the earliest stages of viable pregnancies, and ways to minimize the likelihood of negative consequences of delivery in these patients.
John Allbert, MD
Novant Health Maternal-Fetal Medicine Associates
Charlotte, NC
Dr. John Allbert has been in private practice for the past 10 years and prior to that was an associate clinical professor at the University of North Carolina School of Medicine while teaching at Carolinas Medical Center . In the past Dr. Allbert was president of the North Carolina Obstetrics and Gynecology Society and is currently the North Carolina ACOG section chair for district IV. He is involved with SMFM as a member of the Finance committee and the Health Policy and Advocacy Committee. Dr. Allbert is also the SMFM representative for the OB/GYN PAC Governing committee.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More